Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review

KDG Van de Kant, LJTM van der Sande, Q Jöbsis… - Respiratory …, 2012 - Springer
There is an increasing interest in the potential of exhaled biomarkers, such as volatile
organic compounds (VOCs), to improve accurate diagnoses and management decisions in
pulmonary diseases. The objective of this manuscript is to systematically review the current
knowledge on exhaled VOCs with respect to their potential clinical use in asthma, lung
cancer, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and respiratory
tract infections. A systematic literature search was performed in PubMed, EMBASE …

Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

KD Kant, L Sande, Q Jöbsis, OC Schayck, E Dompeling - 2012 - cabidigitallibrary.org
There is an increasing interest in the potential of exhaled biomarkers, such as volatile
organic compounds (VOCs), to improve accurate diagnoses and management decisions in
pulmonary diseases. The objective of this manuscript is to systematically review the current
knowledge on exhaled VOCs with respect to their potential clinical use in asthma, lung
cancer, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and respiratory
tract infections. A systematic literature search was performed in PubMed, EMBASE …
以上显示的是最相近的搜索结果。 查看全部搜索结果